Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs

Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs

Blog Article

Abstract Introduction There has been renewed interest in mushroom medicinal properties.We studied cholesterol lowering properties of Ganoderma lucidum (Gl), a renowned medicinal species.Results Organic fractions containing oxygenated lanosterol derivatives inhibited cholesterol synthesis in T9A4 here hepatocytes.In hamsters, 5% Gl did not effect LDL; but decreased total cholesterol (TC) 9.8%, and HDL 11.

2%.Gl (2.5 and 5%) had effects on several fecal neutral sterols and bile acids.Both Gl doses reduced hepatic microsomal ex-vivo HMG-CoA reductase activity.In minipigs, 2.

5 Gl decreased TC, LDL- and HDL cholesterol 20, 27, and 18%, respectively (P Conclusions Overall, Gl has potential to reduce LDL cholesterol in color touch 7/97 vivo through various mechanisms.Next steps are to: fully characterize bioactive components in lipid soluble/insoluble fractions; evaluate bioactivity of isolated fractions; and examine human cholesterol lowering properties.Innovative new cholesterol-lowering foods and medicines containing Gl are envisioned.